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SUMMARY 
Objective: To establish the cause(s) of death 
among persons with HIV and AIDS admitted to the 
Fevers Unit of the Korle-Bu Teaching Hospital 
(KBTH) in 2007 and to determine whether they 
were AIDS-relatedin the era of availability of 
HAART 
Method: Retrospective chart review of all deaths 
that occurred in the year 2007 among inpatients 
with HIV infection. Cause of Death (COD) was 
established with post mortem diagnosis, where not 
available ICD-10 was reviewed independently by 
two physicians experienced in HIV medicine and a 
consensus reached as to the most likely COD.  
Results: In the year under review, 215 (97%) of 
the 221 adult deaths studied were caused by AIDS 
and HIV-associated illnesses. Of these, 123 
(55.7%) were due to an AIDS-defining illness as 
described in CDC Category 3 or WHO stage 4.  
Infections accounted for most of the deaths 158 
(71.5%), many of them opportunistic 82 (51.8%). 
Tuberculosis was the commonest COD. Clinical 
diagnosis of TB was accurate in 54% of deaths, but 
was not validated by autopsy in 36% of deaths. 
There were few deaths (14.5%) in patients on 
HAART. 
Conclusion: In a developing country like Ghana 
where HAART was still not fully accessible, 
AIDS-related events remained the major causes of 
death in persons living with HIV. Total scale-up of 
the ART programme with continuous availability 
of antiretrovirals is therefore imperative to reduce 
deaths from AIDS and HIV associated illnesses. 
There is need for interventions for early diagnosis 
as well as reduction in late presentation and also 
better diagnostic tools for tuberculosis. 
 




HIV/AIDS is among the leading cause of death worldwide, 
with a yearly toll of 3.1million. Most deaths (2.4 million) 
occur in sub-Saharan Africa.1However, there has been a 
reduction in AIDS-related deaths and a corresponding in-
crease in non-AIDS-related deaths in the era of highly ac-
tive antiretroviral therapy (HAART), especially in devel-
oped nations.2-6 This phenomenon has been attributed to 
the increased longevity and better quality of life afforded 
by HAART.  
 
As more countries scale up antiretrovirals, the phenomenon 
is also being noted across the world in middle and lower 
income countries.3,7,8 AIDS defining illnesses like crypto-
coccal meningitis, herpes simplex encephalitis, cerebral 
toxoplasmosis and extrapulmonary tuberculosis are giving 
way to sepsis, cardiovascular diseases, injuries and non 
AIDS defining cancers. 
 
In developing countries where the majority of HIV-
infected people live, access to HAART has improved, 
however there still remains a substantial unmet need for 
antiretroviral therapy. In the treatment 2015 initiative, the 
UNAIDS recognizes that access to ante-retroviral therapy 
(ART) be scaled up so that 15 million persons without 
ART have access by 2015. Ninety percent of those without 
access who are eligible are found in 30 countries most of 
which are low and middle income countries.9  
 
Initially the high cost and complexity of administration of 
ART in low income countries was considered a barrier but 
evaluation of one of the earliest programmes showed simi-
lar virological, immunological and adverse effect outcome 
as in developed countries.10  
 
Ghana started its ART programme in 2003 and Korle Bu 
Teaching Hospital (KBTH) was one of the initial sites to 
offer ART on a large scale.  
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The study sought to determine the spectrum of 
causes of death (COD) among HIV-infected in-




The Fevers Unit of Korle-Bu Teaching Hospital 
serves as the national referral centre for HIV-
infected patients. Since the first case of HIV was 
diagnosed in Ghana in 1986, the Unit has provided 
care and support to persons living with HIV/AIDS.  
 
In December 2003, the Unit became the third pub-
lic site to provide HAART in the scale-up of access 
to treatment by the National AIDS Control Pro-
gramme (NACP) and its partners. At the time of 
the study there were about 7000 patients enrolled, 
and 3192 of these were receiving HAART. There 
were 716 admissions to the ward in the year under 
study. 
 
We explore here in detail the causes of death 
among HIV-infected patients admitted at the Korle-
Bu Teaching Hospital in the year 2007, 4 years 
after the national HAART programme was 




This was a retrospective study in which the medical 
and mortality records of all HIV-infected patients 
who died at the Fevers Unit during the study period 
(January 2007 to December 2007) were reviewed. 
Data from multiple sources were used and triangu-
lated. The multiple sources included one or more of 
the following: death certificates, medical charts, 
and autopsy reports, where available. The multiple 
sources also included electronic data capture from 
the database as well as manual records from the 
patient folders which included more details of out-
patient as well as all details of inpatient admission. 
Some of the inpatient records were doctors’ notes, 
nurse’s notes and results of laboratory tests. Causes 
of death (COD) were collated from the death certif-
icates and matched with autopsy results.   
 
Where autopsy results were not available, two phy-
sicians experienced in HIV medicine using the 
medical records of admission and concordance 
established did independent determination of the 
most likely cause of death. In cases of discordance, 
a third experienced physician reviewed the records 
and consensus was reached as to the most likely 
primary and secondary CODs, taking into account 
the morbidity at the time of death. Cause of death 
was coded according to the International Classification of 
Diseases, 10th Revision (ICD-10). Variables studied in-
cluded age, gender, duration of admission at the time of 
death, HAART use, and morbidity. “Morbidity” represent-
ed the number of concurrent illnesses present at the time of 
death. 
 
Primary causes of death were classified as “AIDS-related 
death” (ARD), “HIV-associated death” (HIA), or “Other”. 
A death was considered “AIDS-related” when the primary 
COD was an AIDS-defining event as described in Catego-
ry 3 of the CDC definition of AIDS11, or WHO stage 4. 
“HIV-associated deaths” included those conditions that 
were HIV related but not CDC category 3 or WHO stage 4. 
A cause of death not directly attributable to either of the 
foregoing was characterized as “Other”, i.e. non-HIV-
associated. This category included conditions such as he-
patic disease or cardiovascular disease from hypertension. 
 
Causes of death were also sub-categorized by organ sys-
tems and stratified into “Opportunistic infection”, “Oppor-
tunistic malignancy”, or “Other”. Examples of conditions 
falling into this last category were malignancies such as 
hepatocellular carcinoma and metastatic choriocarcinoma. 
 
Data management 
Data was entered into an excel workbook and cleaned. 
Missing data were filled in where available and duplica-
tions removed. The data was then exported into STATA 
version 8.2 and variables coded for analysis. 
 
Statistical Analysis 
Statistical comparisons were made using the chi-squared 
test of hypothesis or Fisher’s exact test, where appropriate. 
P values were two-tailed, and values of <0.05 were consid-
ered statistically significant. All analyses were done using 
a standard statistical package, STATA, version 8.2 (Stata 
Corp., College Station, Texas).  
 
Ethics 
The study protocol was reviewed and approved by the 
Ethical and Protocol Review Committee of the University 




Between January and December 2007, a total of 716 HIV 
and AIDS patients were admitted to the Fevers Unit of 
which 221 of these patients died on admission giving a 
crude mortality rate of 31.5%. Autopsy records were avail-
able for 135 (61%) of the deaths. The mean age was 39.7 
(SD 9.01) and the age range was 18-80 years. Patients in 
the reproductive age group (15-49) made up 187(84.6%) 
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The majority of patients 116 (53%) spent between 
one and six days on admission before death. Only 
32 (14.5%) of the patients were on HAART at the 
time of death (Table 1). 
 
Causes of Death 
Out of the total deaths, 215 (97.3%) were caused 
by conditions associated with HIV and AIDS and 
6(2.7%) were caused by non-HIV related condi-
tions. Of the HIV and AIDS related deaths, 123 
(57.21%) were due to an AIDS-defining illness as 
described in Category 3 of the CDC definition of 
AIDS and therefore were categorized as AIDS-
related deaths (ARD) (Table 2) whereas 92 deaths 
(42.79%) were non AIDS related and classified as 
HIV-associated deaths (HIA). 
 
Table 1 Comparison of patients dying from AIDS 














Age (yrs)    
15-49 103 (83.7) 79 (85.9) 0.81 
>49 20 (16.3) 13 (14.1)  
    
Sex    
Males 61 (49.6) 42 (44.7) 0.71 
Females  63 (50.4) 50 (54.3)  
Duration of Admission at time of death 
<24 hrs 2 (2) 6 (6) 0.85 
1-6 days 65 (55.5) 50 (49.5)  
7 days or more 50 (42.5) 45 (44.5)  
HAART use    
Yes  16 (13.6) 16 (15.8) 0.80 
No 101 (86.4) 85 (84.2)  
Morbidity    
0 concurrent 
illnesses 
48 (41.1) 27 (26.7) <0.01* 
1 concurrent 
illness 
45 (38) 42 (41.6)  
2 concurrent 
illnesses 
23 (20) 20 (19.8)  
3 or more con-
current illnesses 
1 (0.9) 12 (11.9)  
*statistically significant at p<0.05 
 
Tuberculosis was the commonest cause of death 
accounting for 69 (57.7%) of all deaths. This was 
followed closely by cerebral toxoplasmosis and 
Kaposi’s sarcoma. 
 
HIV associated deaths consisted mainly of infec-
tions (47.8%), anaemia (27.2%), malignancy 
(4.3%) and a large miscellaneous group (20.7%) 
consisting of venous thromboembolism, pulmonary 
oedema and others (see Table 3). 
 
Infections were again the commonest cause of HIV associ-
ated deaths majority of which were lobar or bronchopneu-
monia. This was followed closely by anaemia. 
 
Accuracy of Pre-mortem Diagnosis 
Autopsy findings were fully in agreement with pre-mortem 
diagnoses in 24.44% (33) of cases, partial agreement in 
51.85% (70) and not in agreement with 23.70% (32) of 
cases.  
 
Table 2 AIDS Related Deaths 
Infections N=110 N (%) 
Disseminated TB 45(36.5) 
TB meningitis 7   (6.2) 
Pulmonary TB 17 (15) 
Cerebral Toxoplasmosis 26 (23) 
Cryptococcal meningitis 4   (3.5) 
Bacterial meningitis 3  (2.6) 
Chronic diarrhea 8 (7) 
Malignancies N-13  
Kaposi’s sarcoma 10 (8.6) 
Lymphoma   3 (2.6) 
 
Table 3 HIV Associated Deaths 
HIV Associated deaths N-92 N (%) 
Infections 44 (47.8) 
Anaemia 25 (27.2) 
Miscellanous 19 (20.7) 
Malignancy 4 (4.3) 
 
Accuracy of TB Diagnoses 
The ante mortem diagnosis of 69 cases of TB was validat-
ed using post mortem diagnosis. Clinical diagnosis of TB 
was accurate in 37(54%) of TB deaths, but was not validat-
ed by autopsy in 25 (36%) of cases, revealing a considera-
bly high index of suspicion for the disease. The diagnosis 
was missed in 7(10%) of patients. 
 
DISCUSSION 
The causes of death for HIV-infected patients admitted to 
the Fevers Unit in 2007 were examined. The data showed 
that AIDS-related events continued to be the major causes 
of death, in contrast to recent studies conducted in industri-
alized countries which had noted a shift in the causes of 
death toward non-HIV-related causes since the introduc-
tion of HAART.2,12-14 
 
Sackoff 12 noted in his study that from 1999-2004, the per-
centage of deaths from non-HIV causes had increased by 
32%, whereas Palella14 also found that the proportion of 
deaths attributable to non AIDS diseases had increased and 
were predominantly hepatic, cardiovascular, pulmonary 
and non AIDS defining cancers. In the study by De Ollala 
et al4, cause of death from non HIV related causes was 
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In this cohort however, non-AIDS-related causes of 
death such as non-opportunistic malignancies, car-
diovascular, hepatic and renal diseases were un-
common. On the other hand, infections were the 
leading causes of death in this population, notably 
opportunistic infections. Tuberculosis was the sin-
gle most important opportunistic infection causing 
death.  
 
Disseminated TB was the commonest form, with 
pulmonary TB running a close second and TB 
meningitis, third. Likewise in  a study conducted in 
Burkina Faso on determinants and causes of mor-
tality in HIV patients on HAART between 2003 
and 2008, a multivariate analysis showed that clini-
cal stage, BMI, CD4 count and treatment regimen 
were significantly associated with death. Common 
causes of mortality were wasting syndrome, tuber-
culosis and anemia.7  
 
The pattern of diseases causing death in Ghana and 
Burkina Faso could be attributed to the low pene-
tration of antiretroviral therapy amongst the popu-
lation studied and also the fact that these countries 
still continue to have a high burden of communica-
ble diseases as compared to non-communicable 
diseases. The pattern also depicts the severe im-
mune suppression that exists in the in –patients. 
 
In a study by Agaba et al 15 on predictors of mortal-
ity in hospitalized HIV patients in Nigeria, tubercu-
losis was the common diagnosis accounting for 
33.6% of the deaths. Pulmonary disease accounted 
for 53% and extra-pulmonary 47% of TB cases. In 
this study, tuberculosis was again the commonest 
cause of death accounting for 57.7% of all deaths. 
However in contrast to findings from Agaba, dis-
seminated and extrapulmonary accounted for 75% 
of cases whilst pulmonary TB was 25%. 
 
In this study, we have shown that a significant pro-
portion of TB deaths (10%) were not diagnosed 
prior to death. This highlights the need for better 
diagnostic tools for TB a situation which to date 
has only marginally improved. In about three-
quarters of the cases studied, at least one pre-
mortem finding was confirmed by autopsy, attest-
ing to the high clinical acumen of the physicians 
involved and the specificity of the post mortem 
diagnosis. This is in contrast to the study on causes 
of mortality conducted by Sackoff, where he ob-
served that death certificates issued lacked specific-
ity of the cause of death.12 
 
 
With regard to demographic characteristics, patients dying 
from ADIs differed from those dying from non-ADIs only 
in morbidity. This finding was rather surprising as we ex-
pected the opposite, given our definition of morbidity as 
number of concurrent illnesses at the time of death. In a 
study on AIDS and non-AIDS mortality in the era of an-
tiretroviral therapy by Falster et al 16, they found that of 
215 deaths, 89 were AIDS related, 97 non-AIDS related 
and 29 were unknown. They found age greater than 50 
years and CD4 counts > 100 increased the risk of non 
AIDS deaths (HR 4.99) whereas CD4 ≤100 and viral load 
>10,000 increased the risk of AIDS deaths (HR 4.21). 
Most of our patients did not have CD4 counts and viral 
load tests were not available at the time. 
 
Most of the patients in this study were not on HAART at 
the time of their death, suggesting a low admission rate of 
patients on HAART. Even though this rendered analyses 
by HAART use inconclusive, it shows the benefit of 
HAART in reducing morbidity severe enough to warrant 
admission and subsequently mortality. Increased use of 
HAART is likely to reduce mortality as shown in other 
studies around the world.2,12-14  
 
Some of the admissions of patients on HAART were at-
tributed to HAART related anaemia caused by zidovudine, 
one of the first line drugs. Availability and accessibility of 
blood and blood products continue to be a challenge for 
patient care. The relatively short duration of admission for 
most patients reflects the late presentation of HIV-infected 
patients at the health facility hence the high mortality rate. 
 
Limitations of this study include the frequent inadequacy 
of death certificates and medical notes to identify causes of 
death; these are imperfect methods. The autopsy rate was 
just over 60% in this study. Another limitation was that 
immunological and virological parameters were not readily 
available for analysis due to late presentation, short dura-
tion of stay and financial challenges. Virological tests were 
not available at the time. Also, being a tertiary referral cen-
tre, mortality at the Fevers Unit may not be representative 
of HIV mortality in the community but rather in hospitals. 
Mortality in the community can only be ascertained using 
verbal autopsies. 
 
CONCLUSION   
The overall mortality rate for 2007 was 31.5%. AIDS-
related causes accounted for 55.7% whereas HIV-
associated causes accounted for 41.6% of total deaths. To-
gether AIDS and HIV related deaths formed 97% of the 
deaths showing that the transition from HIV related deaths 
to causes of deaths similar to those of the general popula-
tion had not yet occurred in the Unit. Autopsy findings 
confirmed at least one pre-mortem diagnosis in 76% of 
deaths. Tuberculosis was the single most important cause 
of death in the study population.  
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Accuracy of TB diagnosis was average and still 
needed to be supported by better diagnostic tools. 
In a developing country like Ghana where HAART 
is yet to be widely accessible to PLHIVs, HIV-
related deaths remain the major cause of death. 
 
RECOMMENDATIONS 
We recommend further scale-up of the ART pro-
gramme, early diagnosis of individuals and con-
sistent supply of drugs and other consumables to 
reduce HIV related mortality, improve quality of 
life and increase life expectancy. Better diagnostic 
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